ACVIM consensus statement on the treatment of immune‐mediated hemolytic anemia in dogs

Immune‐mediated hemolytic anemia (IMHA) causes severe anemia in dogs and is associated with considerable morbidity and mortality. Treatment with various immunosuppressive and antithrombotic drugs has been described anecdotally and in previous studies, but little consensus exists among veterinarians...

Descripción completa

Detalles Bibliográficos
Autores principales: Swann, James W., Garden, Oliver A., Fellman, Claire L., Glanemann, Barbara, Goggs, Robert, LeVine, Dana N., Mackin, Andrew J., Whitley, Nathaniel T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2019
Materias:
Consensus Statements
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524099/
https://www.ncbi.nlm.nih.gov/pubmed/30847984
http://dx.doi.org/10.1111/jvim.15463

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524099/
https://www.ncbi.nlm.nih.gov/pubmed/30847984
http://dx.doi.org/10.1111/jvim.15463

Ejemplares similares